Complete Remission of BCG-Refractory High-grade Bladder CIS with Pharmacologic Ascorbate and Mistletoe.

Davis, Devra; Seely, Dugald; Morash, Christopher; Armstrong, Jennifer; Meng, Maxwell; Lowe, Phillip; Kogan, Mikhail

Davis, Devra; Seely, Dugald; Morash, Christopher; Armstrong, Jennifer; Meng, Maxwell; Lowe, Phillip; Kogan, Mikhail.

Altern Ther Health Med ; 29(4): 6-17, 2023 May.

Article in En | MEDLINE | ID: mdl-36933241

Subject(s)

Antineoplastic Agents; Carcinoma in Situ; Mistletoe; Urinary Bladder Neoplasms; Humans; Male; Adult; Female; Aged; BCG Vaccine/therapeutic use; Urinary Bladder/pathology; Antineoplastic Agents/therapeutic use; Urinary Bladder Neoplasms/drug therapy; Urinary Bladder Neoplasms/pathology; Mitomycin/adverse effects; Carcinoma in Situ/drug therapy; Carcinoma in Situ/pathology; Carcinogens; Neoplasm Recurrence, Local/chemically induced; Neoplasm Recurrence, Local/drug therapy

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Mistletoe / Urinary Bladder Neoplasms / Carcinoma in Situ / Antineoplastic Agents Type of study: Guideline / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male Language: En Journal: Altern Ther Health Med Year: 2023 Document type: Article

Search on Google

XML

PubMed Links